Completed
Study to Evaluate the Pharmacokinetic Comparability of CC-93538 From Two Different Drug Concentrations in Healthy Adult Subjects - CC-93538-CP-002
Aggiornato:
24 settembre, 2021
|
ClinicalTrials.gov
Celgene e’ interamente controllata da Bristol-Myers Squibb Company
Sintesi in un linguaggio semplice